Cargando…
Deep Vein Thrombosis Prophylaxis in Trauma Patients
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are known collectively as venous thromboembolism (VTE). Venous thromboembolic events are common and potentially life-threatening complications following trauma with an incidence of 5 to 63%. DVT prophylaxis is essential in the management of trau...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195354/ https://www.ncbi.nlm.nih.gov/pubmed/22084663 http://dx.doi.org/10.1155/2011/505373 |
_version_ | 1782214120889647104 |
---|---|
author | Toker, Serdar Hak, David J. Morgan, Steven J. |
author_facet | Toker, Serdar Hak, David J. Morgan, Steven J. |
author_sort | Toker, Serdar |
collection | PubMed |
description | Deep vein thrombosis (DVT) and pulmonary embolism (PE) are known collectively as venous thromboembolism (VTE). Venous thromboembolic events are common and potentially life-threatening complications following trauma with an incidence of 5 to 63%. DVT prophylaxis is essential in the management of trauma patients. Currently, the optimal VTE prophylaxis strategy for trauma patients is unknown. Traditionally, pelvic and lower extremity fractures, head injury, and prolonged immobilization have been considered risk factors for VTE; however it is unclear which combination of risk factors defines a high-risk group. Modalities available for trauma patient thromboprophylaxis are classified into pharmacologic anticoagulation, mechanical prophylaxis, and inferior vena cava (IVC) filters. The available pharmacologic agents include low-dose heparin (LDH), low molecular weight heparin (LMWH), and factor Xa inhibitors. Mechanical prophylaxis methods include graduated compression stockings (GCSs), pneumatic compression devices (PCDs), and A-V foot pumps. IVCs are traditionally used in high risk patients in whom pharmacological prophylaxis is contraindicated. Both EAST and ACCP guidelines recommend primary use of LMWHs in trauma patients; however there are still controversies regarding the definitive VTE prophylaxis in trauma patients. Large randomized prospective clinical studies would be required to provide level I evidence to define the optimal VTE prophylaxis in trauma patients. |
format | Online Article Text |
id | pubmed-3195354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-31953542011-11-14 Deep Vein Thrombosis Prophylaxis in Trauma Patients Toker, Serdar Hak, David J. Morgan, Steven J. Thrombosis Review Article Deep vein thrombosis (DVT) and pulmonary embolism (PE) are known collectively as venous thromboembolism (VTE). Venous thromboembolic events are common and potentially life-threatening complications following trauma with an incidence of 5 to 63%. DVT prophylaxis is essential in the management of trauma patients. Currently, the optimal VTE prophylaxis strategy for trauma patients is unknown. Traditionally, pelvic and lower extremity fractures, head injury, and prolonged immobilization have been considered risk factors for VTE; however it is unclear which combination of risk factors defines a high-risk group. Modalities available for trauma patient thromboprophylaxis are classified into pharmacologic anticoagulation, mechanical prophylaxis, and inferior vena cava (IVC) filters. The available pharmacologic agents include low-dose heparin (LDH), low molecular weight heparin (LMWH), and factor Xa inhibitors. Mechanical prophylaxis methods include graduated compression stockings (GCSs), pneumatic compression devices (PCDs), and A-V foot pumps. IVCs are traditionally used in high risk patients in whom pharmacological prophylaxis is contraindicated. Both EAST and ACCP guidelines recommend primary use of LMWHs in trauma patients; however there are still controversies regarding the definitive VTE prophylaxis in trauma patients. Large randomized prospective clinical studies would be required to provide level I evidence to define the optimal VTE prophylaxis in trauma patients. Hindawi Publishing Corporation 2011 2011-05-15 /pmc/articles/PMC3195354/ /pubmed/22084663 http://dx.doi.org/10.1155/2011/505373 Text en Copyright © 2011 Serdar Toker et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Toker, Serdar Hak, David J. Morgan, Steven J. Deep Vein Thrombosis Prophylaxis in Trauma Patients |
title | Deep Vein Thrombosis Prophylaxis in Trauma Patients |
title_full | Deep Vein Thrombosis Prophylaxis in Trauma Patients |
title_fullStr | Deep Vein Thrombosis Prophylaxis in Trauma Patients |
title_full_unstemmed | Deep Vein Thrombosis Prophylaxis in Trauma Patients |
title_short | Deep Vein Thrombosis Prophylaxis in Trauma Patients |
title_sort | deep vein thrombosis prophylaxis in trauma patients |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195354/ https://www.ncbi.nlm.nih.gov/pubmed/22084663 http://dx.doi.org/10.1155/2011/505373 |
work_keys_str_mv | AT tokerserdar deepveinthrombosisprophylaxisintraumapatients AT hakdavidj deepveinthrombosisprophylaxisintraumapatients AT morganstevenj deepveinthrombosisprophylaxisintraumapatients |